{"filings":[{"id":1140599,"accession_number":"0001628280-26-044414","cik":1822359,"company_name":"DocGo Inc.","ticker":"DCGO","form_type":"8-K","filed_at":"2026-06-18T21:06:04+00:00","items":["5.07"],"status":"ready","headline":"DocGo shareholders approve reverse stock split, reject two charter amendments","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Elected directors Vina Leite (31.2M votes for) and James M. Travers (25.1M votes for) to Class II.","Approved reverse stock split at ratios 1:5 to 1:10, at board's discretion (66.1M for, 5.7M against).","Advisory 'say-on-pay' executive compensation approved (39.8M for, 10.2M against).","Two charter amendments (corporate opportunity waiver and officer exculpation) failed to receive stockholder approval.","Ratified Urish Popeck & Co., LLC as auditor for FY2026 (67.6M for, 3.9M against)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":63563910.896159306,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":13046,"accession_number":"0001822359-26-000020","cik":1822359,"company_name":"DocGo Inc.","ticker":"DCGO","form_type":"8-K","filed_at":"2026-05-11T20:09:20+00:00","items":["2.02","9.01"],"status":"ready","headline":"DocGo Q1 revenue $75.6M (down 21% YoY) as migrant programs end; raises FY rev guidance to $300-315M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue $75.6M vs $96.0M YoY; migrant-related revenue zero vs $35M. Ex-migrant revenue up 19.3% to $75.6M.","GAAP net loss ($16.7M) vs ($11.1M); adjusted EBITDA loss ($10.2M) vs ($3.9M). Adjusted gross margin 31.6% vs 32.1%.","Mobile Health Services revenue $23.6M (ex-migrant up 131%); Medical Transportation $51.9M (+2.2%).","Cash $59.9M at Mar 31 vs $68.3M at Dec 31, 2025. Company raised FY2026 revenue guidance to $300-315M from $290-310M.","Achieved record volumes across major lines; SteadyMD signed virtual care contract with leading online pharmacy."],"consensus_eps_estimate":-0.0952,"consensus_eps_actual":-0.15,"consensus_revenue_estimate":null,"consensus_revenue_actual":75550484.0,"consensus_period":"2026-Q1","consensus_source":"xbrl+finnhub","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":63563910.896159306,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":95831,"accession_number":"0001822359-26-000017","cik":1822359,"company_name":"DocGo Inc.","ticker":"DCGO","form_type":"8-K","filed_at":"2026-04-22T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"DocGo: Director Klasko to step down; Burdiek named independent Chair; special committee for cost reduction","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Dr. Stephen Klasko will step down from the Board effective after the 2026 Annual Meeting on June 16, 2026, due to a new healthcare leadership role.","Klasko's departure was not due to any disagreement with DocGo regarding operations, disclosures, policies, or practices.","Michael Burdiek, an independent director, was appointed as independent Chair of the Board, effective at the same time as Klasko's departure.","Jim Travers was appointed to the Audit and Compliance Committee and the Nominating and Corporate Governance Committee, replacing Klasko immediately prior to the effective time.","On April 21, 2026, the Board formed a special committee (Vina Leite, Ira Smedra, Michael Burdiek) to identify corporate efficiencies and cost reduction opportunities."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":63563910.896159306,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109162,"accession_number":"0001822359-26-000009","cik":1822359,"company_name":"DocGo Inc.","ticker":"DCGO","form_type":"8-K","filed_at":"2026-03-16T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"DocGo Q4 2025 revenue $74.9M, net loss $142.3M; raises 2026 guidance; exploring strategic alternatives","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2025 revenue $74.9M (down 38% YoY due to migrant wind-down); net loss $142.3M vs $7.6M loss in Q4 2024.","Full year 2025 revenue $322.2M (down from $616.6M); net loss $196.4M; adjusted EBITDA loss $28.6M.","Raises 2026 guidance: revenue $290-310M (prev $280-300M), adj EBITDA loss $5-10M (prev $15-25M loss).","Initiated formal process to explore strategic alternatives to maximize shareholder value.","'Healthcare at any address' revenue tripled to $12.8M in Q4; record volumes across medical transportation and mobile health."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":63563910.896159306,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109161,"accession_number":"0001822359-26-000003","cik":1822359,"company_name":"DocGo Inc.","ticker":"DCGO","form_type":"8-K","filed_at":"2026-01-30T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"DocGo receives Nasdaq deficiency notice for bid price below $1.00","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Nasdaq notified DocGo on Jan 26, 2026 of non-compliance with minimum bid price rule; closing bid below $1.00 from Dec 9, 2025 to Jan 23, 2026.","Company has 180 days, until July 27, 2026, to regain compliance by closing bid >= $1.00 for 10 consecutive business days.","If not compliant by July 27, DocGo may qualify for a second 180-day period if it meets other standards and intends to cure.","DocGo is evaluating options including a potential reverse stock split to regain compliance.","Listing remains fully effective; no immediate delisting action."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":63563910.896159306,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":125661,"accession_number":"0001822359-25-000080","cik":1822359,"company_name":"DocGo Inc.","ticker":"DCGO","form_type":"8-K","filed_at":"2025-12-12T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"DocGo extends $26M share repurchase program expiration to June 30, 2026","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board extended buyback deadline from Dec 31, 2025 to June 30, 2026; no other changes.","Authorized amount remains unchanged at up to $26 million of common stock.","Repurchases may occur via open market, private deals, or Rule 10b5-1 plans.","Program retains flexibility: may be modified, suspended, or discontinued at any time.","Funding sources include cash, cash flow, or borrowings."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":63563910.896159306,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":125660,"accession_number":"0001628280-25-051026","cik":1822359,"company_name":"DocGo Inc.","ticker":"DCGO","form_type":"8-K","filed_at":"2025-11-10T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"DocGo Q3 revenue $70.8M, net loss $29.7M; migrant wind-down drives decline","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $70.8M (-49% YoY); ex-migrant rev $62.4M (+8%). Migrant rev fell to $8.4M from $80.7M.","GAAP net loss $29.7M (incl $16.7M impairments) vs $4.5M income; adj EBITDA loss $7.2M vs $17.9M.","Cash $95.2M vs $128.7M; repaid $30M line of credit; operating cash flow $1.7M.","FY2025 rev guidance narrowed to $315-320M (incl $68-70M migrant); adj EBITDA loss $25-28M.","FY2026 rev outlook $280-300M (zero migrant); adj EBITDA loss $15-25M; base biz growth 12-20%."],"consensus_eps_estimate":-0.118,"consensus_eps_actual":-0.49,"consensus_revenue_estimate":null,"consensus_revenue_actual":247260312.0,"consensus_period":"2025-Q3","consensus_source":"xbrl+finnhub","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":63563910.896159306,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":125658,"accession_number":"0001213900-25-100516","cik":1822359,"company_name":"DocGo Inc.","ticker":"DCGO","form_type":"8-K/A","filed_at":"2025-10-21T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"DocGo acquires SteadyMD for up to $25M; common/preferred holders receive no closing cash","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Acquisition via merger: $12.5M cash at closing plus up to $12.5M contingent earn-out.","Series B preferred liquidation preference ($49.7M) exceeds total consideration; no distribution to common or preferred at closing.","Convertible noteholders paid 2.5x principal plus interest at closing ($12.5M CNI payoff).","Earn-out contingent on performance; only Series B preferred eligible after convertible debt fully settled.","Merger approved by SteadyMD board; stockholder consent obtained; closing occurred October 20, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":63563910.896159306,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":125659,"accession_number":"0001213900-25-100412","cik":1822359,"company_name":"DocGo Inc.","ticker":"DCGO","form_type":"8-K","filed_at":"2025-10-20T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"DocGo acquires SteadyMD for up to $25M, expands telehealth across 50 states","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Acquisition price up to $25M: $12.5M cash at close + up to $12.5M contingent earn-out.","SteadyMD expected to generate ~$25M revenue in 2025; served 3M patients with 600+ clinicians.","Co-founders Guy Friedman and Yarone Goren join DocGo leadership team.","DocGo to fund from existing cash; plans to update 2025 guidance in early November.","SteadyMD’s 50-state virtual care platform complements DocGo’s mobile health last-mile delivery."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":63563910.896159306,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142387,"accession_number":"0001822359-25-000077","cik":1822359,"company_name":"DocGo Inc.","ticker":"DCGO","form_type":"8-K","filed_at":"2025-08-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"DocGo Q2 revenue halved to $80.4M from migrant wind-down; net loss $13.3M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $80.4M vs $164.9M YoY due to planned migrant program wind-down; net loss $13.3M vs net income $5.9M.","Adjusted EBITDA loss $6.1M vs positive $17.2M in Q2 2024.","Cash and investments $128.7M (up $25.6M QoQ); subsequent $30M debt paydown brings credit line to zero.","Mobile Health revenue $30.8M (-74% YoY); Transportation $49.6M (+3% YoY).","FY2025 guidance reiterated: revenue $300-330M, adj. EBITDA loss $20-30M."],"consensus_eps_estimate":-0.0962,"consensus_eps_actual":-0.21,"consensus_revenue_estimate":null,"consensus_revenue_actual":176450677.0,"consensus_period":"2025-Q2","consensus_source":"xbrl+finnhub","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":63563910.896159306,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":160420,"accession_number":"0001822359-25-000062","cik":1822359,"company_name":"DocGo Inc.","ticker":"DCGO","form_type":"8-K","filed_at":"2025-06-18T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"DocGo shareholders reject two charter amendments at 2025 annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Elected three Class I directors: Bienstock (57.2M for), Tendler (50.7M for), Smedra (43.9M for).","Say-on-pay approved: 47.9M for, 18.2M against, 0.9M abstain.","Corporate opportunity waiver amendment failed: 63.7M for, 2.1M against, but required >66.7% of outstanding shares? (note: not approved).","Officer exculpation amendment also failed: 60.0M for, 6.2M against.","Ratification of auditor Urish Popeck & Co. passed: 76.7M for, 4.8M against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.15,"market_cap_usd":63563910.896159306,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":160419,"accession_number":"0001822359-25-000060","cik":1822359,"company_name":"DocGo Inc.","ticker":"DCGO","form_type":"8-K","filed_at":"2025-06-12T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"DocGo extends $26M share repurchase program expiration to Dec 31, 2025","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board extended repurchase program expiration from June 30, 2025 to December 31, 2025.","Program authorizes up to $26 million in common stock repurchases; no other changes.","Repurchases may occur via open market, private transactions, or Rule 10b5-1 plans.","Company's timing and number of shares depend on market conditions and other factors."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":63563910.896159306,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":160418,"accession_number":"0001822359-25-000040","cik":1822359,"company_name":"DocGo Inc.","ticker":"DCGO","form_type":"8-K","filed_at":"2025-05-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"DocGo Q1 revenue $96M (down 50% YoY); slashes 2025 guidance to $300-330M, expects negative adjusted EBITDA","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q1 2025 revenue $96.0M vs $192.1M YoY; net loss $11.1M vs net income $10.6M.","Adjusted EBITDA loss $3.9M vs $24.1M YoY; GAAP gross margin 28.2% vs 32.8%.","Full-year revenue guidance lowered to $300-330M (from $410-450M); adjusted EBITDA loss of $20-30M expected.","Guidance revision driven by removal of all non-migrant Government Population Health revenue due to policy uncertainty.","Cash $103.1M; repurchased 1.95M shares for $5.8M; expects positive cash flow from migrant receivables."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.09,"consensus_revenue_estimate":null,"consensus_revenue_actual":96033055.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":63563910.896159306,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":178681,"accession_number":"0001822359-25-000017","cik":1822359,"company_name":"DocGo Inc.","ticker":"DCGO","form_type":"8-K","filed_at":"2025-02-27T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"DocGo Q4 revenue $120.8M, net loss $7.6M; FY 2025 EBITDA margin guidance cut to ~5%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2024 revenue $120.8M, down from $199.2M Q4 2023 on migrant wind-down; net loss $7.6M vs net income $8.0M.","Full-year 2024 revenue $616.6M (down 1.2% YoY), net income $13.4M, adjusted EBITDA $60.3M (up from $54.0M).","2025 revenue guidance unchanged at $410-450M; adjusted EBITDA margin guidance cut to ~5% from previous 8-10%.","Migrant program wind-down reduced Q4 revenue by ~$9M and EBITDA by $5.3M; increased loss reserves cut EBITDA by $3.2M.","Surpassed 700,000 patient lives assigned for care gap closure programs; Q4 NPS of 86 for these programs."],"consensus_eps_estimate":null,"consensus_eps_actual":0.18,"consensus_revenue_estimate":null,"consensus_revenue_actual":616555132.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":63563910.896159306,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":195342,"accession_number":"0001822359-24-000119","cik":1822359,"company_name":"DocGo Inc.","ticker":"DCGO","form_type":"8-K","filed_at":"2024-12-20T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"DocGo extends share repurchase program expiration to June 30, 2025","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board extended expiration of $26M share repurchase program from Dec 31, 2024 to June 30, 2025.","No changes to program terms; repurchases may occur in open market or privately during open windows.","Repurchases may be funded from cash, future cash flow, or debt; program can be modified or suspended anytime."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":63563910.896159306,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":195341,"accession_number":"0001822359-24-000092","cik":1822359,"company_name":"DocGo Inc.","ticker":"DCGO","form_type":"8-K","filed_at":"2024-11-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"DocGo Q3 2024 revenue falls 26% to $138.7M; raises FY2024 cash flow guidance to $90-100M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 revenue $138.7M (-26% YoY) from migrant program wind down; net income $4.5M (flat YoY).","Adjusted EBITDA $17.9M (+7% YoY); adjusted gross margin improved to 36.0% from 29.5%.","FY2024 revenue guidance tightened to $620-630M; adj. EBITDA guided to $70-75M; cash flow ops raised to $90-100M.","FY2025 revenue expected $410-450M with adj. EBITDA margin of 8%-10%.","Care gap closure patients >500k; expanded West Coast operations; Dr. Stephen Klasko appointed board chair."],"consensus_eps_estimate":null,"consensus_eps_actual":0.22,"consensus_revenue_estimate":null,"consensus_revenue_actual":495722059.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":63563910.896159306,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":211604,"accession_number":"0001822359-24-000085","cik":1822359,"company_name":"DocGo Inc.","ticker":"DCGO","form_type":"8-K","filed_at":"2024-09-30T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"DocGo appoints Dr. Stephen K. Klasko as independent Chair; Steven Katz resigns","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Dr. Klasko appointed Class III director and independent Chair of Board effective October 1, 2024.","He previously led Jefferson Health (18 hospitals, 35K employees) and is a Special Advisor at General Catalyst.","Steven Katz resigned as Chair and director; will consult through Dec 31, 2024, at $2,500/month plus $400/hour over 5 hours.","Dr. Klasko receives $500K one-time stock option grant (1-year vest) and $300K cash compensation for first year as Chair.","Katz's departure was not due to any disagreement with the Company."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":63563910.896159306,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":211603,"accession_number":"0001822359-24-000079","cik":1822359,"company_name":"DocGo Inc.","ticker":"DCGO","form_type":"8-K","filed_at":"2024-08-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"DocGo Q2 revenue $164.9M (+31% YoY), net income $5.9M; raises cash flow guidance to $80-90M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $164.9M (up 31% YoY); net income $5.9M (up 354%); adjusted EBITDA $17.2M (up 89%).","Mobile Health revenue $116.7M (+46% YoY); Transportation $48.2M (+6%). Cash $85.8M.","Cash from ops guidance raised to $80-90M from $70-80M. Revenue & adj EBITDA guidance reiterated.","Board authorized $26M share repurchase program through year-end. Won 5 new contracts & expanded programs."],"consensus_eps_estimate":null,"consensus_eps_actual":0.17,"consensus_revenue_estimate":null,"consensus_revenue_actual":357037245.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":63563910.896159306,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":230309,"accession_number":"0001822359-24-000058","cik":1822359,"company_name":"DocGo Inc.","ticker":"DCGO","form_type":"8-K","filed_at":"2024-06-18T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"DocGo Inc. announces 2024 Annual Meeting results; all proposals approved by stockholders","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Both Class III director nominees Steven Katz and Michael Burdiek elected with 38.8M and 50.7M votes for respectively.","Advisory vote on named executive officer compensation approved (38.2M for, 14.6M against).","Stockholders favored annual advisory vote on executive compensation; Board adopts annual frequency until next required vote.","Ratification of Urish Popeck & Co., LLC as independent auditor for FY 2024 approved (74.3M for, 914K against)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"market_cap_usd":63563910.896159306,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":230308,"accession_number":"0001822359-24-000043","cik":1822359,"company_name":"DocGo Inc.","ticker":"DCGO","form_type":"8-K","filed_at":"2024-05-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"DocGo Q1 revenue up 70% to $192.1M; guides FY revenue down to $600-650M on migrant wind-down","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income of $10.6M vs loss of $3.9M YoY; record adjusted EBITDA $24.1M, up 330%.","Mobile Health revenue $143.9M (+97%); Transportation $48.2M (+20%); gross margin 35.0% vs 28.1%.","FY 2024 revenue guidance cut to $600-650M (from $720-750M); adjusted EBITDA guidance $65-75M (from $80-85M).","Base business (non-migrant) expected $280-300M in 2024, targeting >30% growth and >10% EBITDA margin in 2025.","Repurchased 2.7M shares at avg $3.69 since Jan 30, 2024; $26M remaining in buyback plan."],"consensus_eps_estimate":null,"consensus_eps_actual":0.1,"consensus_revenue_estimate":null,"consensus_revenue_actual":192087529.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":63563910.896159306,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":230307,"accession_number":"0001822359-24-000037","cik":1822359,"company_name":"DocGo Inc.","ticker":"DCGO","form_type":"8-K","filed_at":"2024-05-07T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"DocGo discloses cybersecurity incident involving protected health information in ambulance business","summary_kind":"llm","event_type":"cyber","confidence":"high","bullets":["Unauthorized access to certain systems; threat actor acquired data including protected health information.","Incident limited to U.S.-based ambulance transportation business; no other business lines involved.","Containment achieved; no evidence of continued unauthorized activity as of May 7, 2024.","Company providing notifications required by applicable law to affected individuals and regulators.","No material impact on operations or financial condition expected to date."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":63563910.896159306,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":230306,"accession_number":"0001822359-24-000035","cik":1822359,"company_name":"DocGo Inc.","ticker":"DCGO","form_type":"8-K","filed_at":"2024-04-10T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"DocGo subsidiary extends NYC asylum-seeker services contract through Dec 2024","summary_kind":"llm","event_type":"other_material","confidence":"medium","bullets":["RRT entered a letter agreement with NYC HPD extending the contract to December 31, 2024.","Extension covers services at hotels outside the five boroughs and transition support for in-borough hotels.","No financial terms of the extension were disclosed in the filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":63563910.896159306,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":248723,"accession_number":"0001822359-24-000018","cik":1822359,"company_name":"DocGo Inc.","ticker":"DCGO","form_type":"8-K","filed_at":"2024-03-08T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"DocGo founder Stan Vashovsky retires as director/chair; CEO Bienstock joins board; Katz new chair","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Stan Vashovsky steps down as director and Chair of Board effective March 31, 2024; remains as consultant until March 31, 2025.","CEO Lee Bienstock appointed to Board as Class I director, effective April 1, 2024.","Director Steven Katz appointed as Chair of the Board, effective April 1, 2024.","During consulting period, Vashovsky will receive quarterly equity grants with ~$35,000 grant-date fair value.","Vashovsky's departure not due to any disagreement; separation includes release of claims and restrictive covenants."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":63563910.896159306,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":248722,"accession_number":"0001822359-24-000014","cik":1822359,"company_name":"DocGo Inc.","ticker":"DCGO","form_type":"8-K","filed_at":"2024-02-28T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"DocGo Q4 revenue $199.2M (+83% YoY); guides 2024 $720-750M rev, $80-85M adj EBITDA","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $199.2M (+83% YoY); net income $8.0M (+13%); adjusted EBITDA $22.6M (+232%).","Full year 2023 revenue $624.2M (+42%); net income $10.0M (-67%); adjusted EBITDA $54.0M (+31%).","2024 guidance: revenue $720-750M, adjusted EBITDA $80-85M, CFO notes moderation in migrant revenue.","Post-year-end collections of $120M, line of credit paid off; share repurchase program up to $36M announced.","Expanded care gap closure services, signed first payer risk-sharing partnership, positive LA Care readmission results."],"consensus_eps_estimate":null,"consensus_eps_actual":0.06,"consensus_revenue_estimate":null,"consensus_revenue_actual":624288642.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":63563910.896159306,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":248721,"accession_number":"0001822359-24-000009","cik":1822359,"company_name":"DocGo Inc.","ticker":"DCGO","form_type":"8-K","filed_at":"2024-01-31T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"DocGo announces $36M share buyback program, cites strong cash position and undervaluation","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board approved up to $36M in share repurchases over 6 months ending July 30, 2024.","Credit agreement amended to allow aggregate repurchases up to $40M (including prior program).","CEO Bienstock states recent share price decline does not reflect company value.","CFO Rosenberg expects to commence purchases after blackout period ends early March.","Repurchases may be funded from existing cash, future cash flow, or debt proceeds."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":63563910.896159306,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":248720,"accession_number":"0001822359-24-000007","cik":1822359,"company_name":"DocGo Inc.","ticker":"DCGO","form_type":"8-K","filed_at":"2024-01-16T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"DocGo refutes short seller claims; projects 40% revenue growth in FY2023","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Select preliminary FY2023 results indicate ~40% revenue growth, following 84% CAGR from 2016-2022.","Claims of Medicare fraud unsubstantiated; company cites routine regulatory reviews with no adverse findings.","Company says $100M liability claim in ABC liquidation of California subsidiary is incorrect; actual liability is not $100M.","DocGo emphasizes VIE structure is standard and consolidated; no Enron-like fraud.","Company sent cease-and-desist to Fuzzy Panda and explores legal recourse."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":63563910.896159306,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":248719,"accession_number":"0001822359-24-000005","cik":1822359,"company_name":"DocGo Inc.","ticker":"DCGO","form_type":"8-K","filed_at":"2024-01-10T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"DocGo rejects Fuzzy Panda short report; guides FY2024 revenue >$700M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["FY2023 revenue expected $615-625M, in line with prior guidance.","FY2024 revenue guidance ~$700M+; full detail in February.","Claims by short seller Fuzzy Panda Research are false and defamatory.","Alleged California liquidation liabilities not company obligations.","States billing compliance program audited externally."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":63563910.896159306,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":266215,"accession_number":"0001822359-23-000031","cik":1822359,"company_name":"DocGo Inc.","ticker":"DCGO","form_type":"8-K","filed_at":"2023-11-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"DocGo Q3 revenue $186.6M (+79% YoY); raises FY23 revenue guidance to $615-$625M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $186.6M (+79% YoY, +49% QoQ); net income $4.6M (+84% YoY).","Adjusted EBITDA $16.7M (+99% YoY); margin 9.0% (vs 8.1% a year ago).","FY23 revenue guidance raised to $615-$625M (from $540-$550M); Adj. EBITDA to $50-$55M.","Backlog grew to $430M total contract value, up from $325M as of August 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.01,"consensus_revenue_estimate":null,"consensus_revenue_actual":425042373.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":63563910.896159306,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":266214,"accession_number":"0001822359-23-000025","cik":1822359,"company_name":"DocGo Inc.","ticker":"DCGO","form_type":"8-K","filed_at":"2023-10-24T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"DocGo receives positive OTDA review; HPD payments commence October 24","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["NYC Comptroller registered HPD agreement Sept 15; DocGo began receiving payments Oct 24, 2023.","OTDA letter confirms required services available at all 14 hotels; residents stated they felt safe with no concerns.","OTDA found food, medical, security, case management services verified; some minor issues (bedbugs, locked rooms) already remedied.","OTDA recommends HPD conduct unannounced site visits every three months; future complaints referred to HPD.","DocGo operates hotels in 7 NY counties housing 1,884 persons as of September 10, 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":63563910.896159306,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":266213,"accession_number":"0001822359-23-000020","cik":1822359,"company_name":"DocGo Inc.","ticker":"DCGO","form_type":"8-K","filed_at":"2023-10-13T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"DocGo finalizes separation agreement with former CEO Anthony Capone; $45k monthly consulting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Anthony Capone resigned as CEO Sept 15; consulting role through March 15, 2024.","Monthly consulting fee of $45,000 plus subsidized COBRA premiums.","No new equity awards; outstanding equity continues vesting during consulting period.","Capone bound by restrictive covenants; severance under prior employment agreement superseded.","Consulting ends immediately for cause; clawback of payments and forfeiture of equity applies."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":63563910.896159306,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":283460,"accession_number":"0001213900-23-077094","cik":1822359,"company_name":"DocGo Inc.","ticker":"DCGO","form_type":"8-K","filed_at":"2023-09-15T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"DocGo CEO Anthony Capone resigns; President Lee Bienstock appointed CEO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Anthony Capone resigned as CEO and all other positions effective September 15, 2023, for personal reasons.","Board appointed current President and COO Lee Bienstock as CEO, effective immediately.","Position of President and COO will remain vacant; no other leadership changes announced.","Bienstock has no family relationships with directors or officers, and no material interest in any related-party transaction."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":63563910.896159306,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":283459,"accession_number":"0001213900-23-074275","cik":1822359,"company_name":"DocGo Inc.","ticker":"DCGO","form_type":"8-K","filed_at":"2023-09-06T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"HPD assures DocGo it will compel NYC Comptroller to process payments under asylum-seeker contract","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["NYC Comptroller returned DocGo's HPD contract without approval on Sept 5.","HPD letter dated Sept 6 says it will inform Comptroller he must take steps for payment.","HPD states there is no risk of non-payment and payment will commence promptly.","Contract is for provision of services to asylum seekers; subsidiary Rapid Reliable Testing NY LLC is counterparty."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":63563910.896159306,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":283458,"accession_number":"0001213900-23-073299","cik":1822359,"company_name":"DocGo Inc.","ticker":"DCGO","form_type":"8-K","filed_at":"2023-09-01T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"DocGo EVP/Treasurer Oberholzer moves to EVP of Strategy; CFO Rosenberg assumes Treasurer role","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Andre Oberholzer steps down as Treasurer and EVP of Capital Markets and Strategy, effective immediately; becomes EVP of Strategy reporting to CEO.","CFO Norman Rosenberg appointed as additional Treasurer role, effective immediately.","Oberholzer no longer considered an officer under Section 16 or Rule 3b-7 of the Exchange Act."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":63563910.896159306,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":283457,"accession_number":"0001213900-23-064067","cik":1822359,"company_name":"DocGo Inc.","ticker":"DCGO","form_type":"8-K","filed_at":"2023-08-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"DocGo Q2 revenue $125.5M, raises FY2023 revenue guidance to $540-550M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue $125.5M, up 15% sequentially; net income $1.3M vs net loss $3.9M in Q1.","Excluding mass COVID-testing (under $1M), core revenue grew 53% YoY.","FY2023 revenue guidance raised to $540-550M, Adjusted EBITDA guidance to $48-53M.","Backlog increased to $325M from $205M as of May 8, driven by Mobile Health wins.","Cash $123.8M, no material debt, $90M undrawn credit line."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.05,"consensus_revenue_estimate":null,"consensus_revenue_actual":238489463.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":63563910.896159306,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":302935,"accession_number":"0001213900-23-050539","cik":1822359,"company_name":"DocGo Inc.","ticker":"DCGO","form_type":"8-K","filed_at":"2023-06-21T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"DocGo shareholders elect two Class II directors, ratify auditor at 2023 annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Vina Leite elected with 57.4M votes for, 3.1M withheld, 16.0M broker non-votes.","James M. Travers elected with 54.6M votes for, 5.8M withheld, 16.0M broker non-votes.","Ratification of Urish Popeck & Co. as auditor for FY 2023: 76.1M for, 270,758 against, 71,168 abstain.","103,094,884 shares entitled to vote as of April 21, 2023 record date."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":63563910.896159306,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":302934,"accession_number":"0001213900-23-049930","cik":1822359,"company_name":"DocGo Inc.","ticker":"DCGO","form_type":"8-K","filed_at":"2023-06-20T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"DocGo holds Investor Day; no material financial updates disclosed","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Investor Day held on June 20, 2023, with presentations on strategy, operations, and clinical excellence.","Presentation covered Proactive Health Care Revolution, Care Delivery Growth Trajectory, and Technology.","No specific financial guidance or performance metrics were provided in the filed presentation except for the agenda.","Presentation is available on the Company's website ir.docgo.com."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":63563910.896159306,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":302933,"accession_number":"0001213900-23-037346","cik":1822359,"company_name":"DocGo Inc.","ticker":"DCGO","form_type":"8-K","filed_at":"2023-05-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"DocGo Q1 revenue $113M, net loss $3.9M; reaffirms FY2023 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q1 revenue $113.0M, down 4.2% YoY; ex-COVID testing, revenue up 40.2%.","Net loss of $3.9M vs. net income of $9.4M in Q1 2022; Adj. EBITDA $5.6M.","Gross margin 28.1% vs 33.9% YoY; cites startup costs from new project, expects recovery.","Backlog rose to $205M from $180M; active RFPs doubled to ~$1.5B lifetime value.","Reiterates FY2023 revenue guidance $500-$510M and Adj. EBITDA $45-$50M."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.03,"consensus_revenue_estimate":null,"consensus_revenue_actual":113002703.0,"consensus_period":"2023-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":63563910.896159306,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":302932,"accession_number":"0001213900-23-031044","cik":1822359,"company_name":"DocGo Inc.","ticker":"DCGO","form_type":"8-K/A","filed_at":"2023-04-19T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"DocGo appoints Vina Leite to Compensation and Nominating committees","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Vina Leite was elected as a Class II director effective November 10, 2022, when the Board was expanded to seven members.","On April 18, 2023, the Board appointed Ms. Leite to the Compensation Committee and the Nominating and Corporate Governance Committee.","Ms. Leite had not previously served on any Board committees since her election."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":63563910.896159306,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":322574,"accession_number":"0001213900-23-022089","cik":1822359,"company_name":"DocGo Inc.","ticker":"DCGO","form_type":"8-K/A","filed_at":"2023-03-22T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"DocGo appoints President, Treasurer, CFO; approves salary increases and stock option grants","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Lee Bienstock appointed President (in addition to COO); salary raised to $490K from $415K, target bonus increased to 80% from 50%.","Andre Oberholzer named Treasurer and EVP of Capital Markets; salary raised to $490K, bonus to 75% from 60%; granted stock option valued at ~$831K.","Norman Rosenberg appointed CFO (continuing as Ambulnz CFO); salary raised to $425K from $321K, bonus to 75% from 38%; granted stock option valued at ~$531K.","Fully vested stock grants awarded as make-whole for retroactive salary increases: Bienstock ~$18.8K, Oberholzer ~$19.5K, Rosenberg ~$26K.","Compensation changes effective April 1, 2023; stock awards and options effective third trading day after Q1 2023 10-Q filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":63563910.896159306,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":322573,"accession_number":"0001213900-23-022085","cik":1822359,"company_name":"DocGo Inc.","ticker":"DCGO","form_type":"8-K/A","filed_at":"2023-03-22T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"DocGo raises CEO salary to $600k, approves stock awards worth ~$410k","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Base salary increased from $425,000 to $600,000; target bonus raised from 73% to 100% of base, effective Apr 1, 2023.","Fully vested stock grant of $43,750 approved as retroactive pay adjustment to Jan 1, 2023.","Stock option award with grant date fair value of approximately $366,000, vesting equally over four years.","Both equity grants effective on third trading day after filing of Q1 2023 Form 10-Q.","Compensation changes approved by Board and Compensation Committee on March 16-18, 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":63563910.896159306,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":322575,"accession_number":"0001213900-23-019594","cik":1822359,"company_name":"DocGo Inc.","ticker":"DCGO","form_type":"8-K","filed_at":"2023-03-13T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"DocGo FY2022 revenue $440.5M (+38% YoY); guides 2023 revenue $500-$510M, Adj. EBITDA $45-50M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Full-year 2022 revenue $440.5M, up 38% YoY; net income $30.7M (+60%); Adjusted EBITDA $41.3M (+65%).","Q4 revenue $108.8M vs $121.3M (Q4 2021 had $50M COVID revenue); transport revenue up 98% to $37M.","2023 guidance: revenue $500-510M (14-16% as-reported, 36-40% ex-COVID); Adj. EBITDA $45-50M; gross margin ~35%.","Backlog of $180M over three years; 34 active RFPs totaling over $1B; $90M Citibank credit line unused.","Since Jan 2023, awarded over $180M in new business across US and UK, including health system contracts; hiring hundreds, adding 100+ vehicles."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":63563910.896159306,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":340592,"accession_number":"0001213900-22-083352","cik":1822359,"company_name":"DocGo Inc.","ticker":"DCGO","form_type":"8-K","filed_at":"2022-12-29T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"DocGo CEO Vashovsky retires but stays as non-executive Chairman; Capone becomes CEO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Stan Vashovsky steps down as CEO effective Dec 31, 2022, but remains non-executive Chairman from Jan 1, 2023.","President Anthony Capone succeeds Vashovsky as CEO effective Jan 1, 2023.","Ira Smedra, previously to become Chairman, continues as director instead.","Vashovsky receives quarterly equity grants (~$79,500 each) and COBRA coverage as Chairman."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":63563910.896159306,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":340591,"accession_number":"0001213900-22-071594","cik":1822359,"company_name":"DocGo Inc.","ticker":"DCGO","form_type":"8-K","filed_at":"2022-11-14T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"DocGo appoints Leite to board, promotes Bienstock to President, names Rosenberg CFO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Appointed Vina Leite, Chief People Officer at GoodRx, to its Board of Directors.","COO Lee Bienstock promoted to additional role of President, effective December 31, 2022.","CFO Andre Oberholzer becomes Treasurer & EVP of Capital Markets; Norman Rosenberg succeeds as CFO.","Leite receives initial stock option grant with Black-Scholes value of $320,000, vesting over 3 years.","No transactions requiring Item 404(a) disclosure for any appointee."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":63563910.896159306,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":340590,"accession_number":"0001213900-22-069776","cik":1822359,"company_name":"DocGo Inc.","ticker":"DCGO","form_type":"8-K","filed_at":"2022-11-07T23:59:59+00:00","items":["2.02","5.02","9.01"],"status":"ready","headline":"DocGo Q3 revenue $104.3M (+22% YoY), net income up 213%; raises FY guidance, CEO retiring","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 revenue $104.3M (up 22% YoY); net income $2.5M vs $0.8M (up 213%); adj. EBITDA $8.4M vs $4.0M (up 110%).","FY2022 revenue guidance raised to $430-440M (prior $425-435M); adj. EBITDA guidance raised to $41-46M (prior $40-45M).","Co-founder & CEO Stan Vashovsky retiring Dec 31, 2022; President Anthony Capone appointed as new CEO, effective same date.","Mobile Health revenue $76.6M (+12.9%); Transportation revenue $27.7M (+55%). Cash $179.4M plus undrawn $90M Citi credit line.","Mass COVID testing fell to mid-single-digit % of revenue vs 35% in Q3 2021; last contracts ended September 2022."],"consensus_eps_estimate":null,"consensus_eps_actual":0.24,"consensus_revenue_estimate":null,"consensus_revenue_actual":331730750.0,"consensus_period":"2022-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":63563910.896159306,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":340589,"accession_number":"0001213900-22-068671","cik":1822359,"company_name":"DocGo Inc.","ticker":"DCGO","form_type":"8-K","filed_at":"2022-11-02T23:59:59+00:00","items":["1.01","2.03","7.01","9.01"],"status":"ready","headline":"DocGo enters $90M revolving credit facility with Citibank; includes $50M accordion option","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$90M secured line of credit with Citibank as administrative agent, five-year maturity.","Facility includes a $50M accordion option to increase commitments, subject to lender consent.","Revolving facility was undrawn as of November 1, 2022.","Funds intended for opportunistic M&A and working capital; CFO cites strong balance sheet and positive cash flow.","Interest rate based on SOFR or base rate plus applicable margin (initial SOFR margin 1.25%), tied to leverage ratio."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":63563910.896159306,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":357852,"accession_number":"0001213900-22-048260","cik":1822359,"company_name":"DocGo Inc.","ticker":"DCGO","form_type":"8-K","filed_at":"2022-08-16T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"DocGo redeems all outstanding warrants at $0.10 each; deadline Sept 16, 2022","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Redemption price of $0.10 per warrant; warrants must be exercised by 5:00pm ET on Sept 16 or become void.","Cash exercise at $11.50/share or cashless exercise at 0.2233 shares per warrant; stock closed at $10.18 on Aug 12.","Redemption triggered by common stock closing above $10.00 per share; last trading day for warrants expected Sept 15.","Outstanding warrants include public (DCGOW) and private warrants from 2020 IPO; warrant agent is Continental Stock Transfer."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":63563910.896159306,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":357851,"accession_number":"0001213900-22-045435","cik":1822359,"company_name":"DocGo Inc.","ticker":"DCGO","form_type":"8-K","filed_at":"2022-08-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"DocGo Q2 revenue $109.5M (+76% YoY), raises FY2022 guidance to $425-435M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $109.5M, up 76% YoY from $62.2M; net income $11.8M vs $0.1M.","Adjusted EBITDA $12.3M vs $3.4M; mobile health revenue $87.3M (+163% YoY).","Full-year 2022 revenue guidance raised to $425-435M from $400-420M; Adjusted EBITDA guidance $40-45M.","Approved $40M share repurchase program; expanded contracts with Carnival, L.A. Care, Empire BlueCross.","Six-month revenue $227.4M (+104% YoY); cash $208.4M at quarter end."],"consensus_eps_estimate":null,"consensus_eps_actual":0.2,"consensus_revenue_estimate":null,"consensus_revenue_actual":227410856.0,"consensus_period":"2022-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":63563910.896159306,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":376495,"accession_number":"0001213900-22-034364","cik":1822359,"company_name":"DocGo Inc.","ticker":"DCGO","form_type":"8-K","filed_at":"2022-06-22T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"DocGo Inc. elects three Class I directors, ratifies auditor at 2022 annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Stan Vashovsky elected with 64.3M for, 4.2M withheld; Ira Smedra 63.1M for, 5.4M withheld.","Ely D. Tendler elected with 63.9M for, 4.6M withheld; broker non-votes of 10.7M on all three.","Ratification of Urish Popeck & Co. as auditor for FY2022 carried with 79.2M for, 38k against, 62k abstain.","Meeting held on June 20, 2022; record date April 25, 2022 with 100,345,233 shares entitled to vote."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"market_cap_usd":63563910.896159306,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":376494,"accession_number":"0001213900-22-029143","cik":1822359,"company_name":"DocGo Inc.","ticker":"DCGO","form_type":"8-K","filed_at":"2022-05-24T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"DocGo announces $40M share repurchase program, citing strong cash position and confidence","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board authorizes repurchase of up to $40M of common stock; program expires Nov 24, 2023.","CEO Stan Vashovsky cites rapid revenue growth, substantial free cash flow, and $199M cash balance.","Repurchases may be made via open market, private deals, or 10b5-1 plans; Citigroup to act as broker.","Company reaffirms commitment to enhancing shareholder value; program may be modified or suspended anytime."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":63563910.896159306,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":376493,"accession_number":"0001213900-22-024978","cik":1822359,"company_name":"DocGo Inc.","ticker":"DCGO","form_type":"8-K","filed_at":"2022-05-10T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"DocGo Q1 revenue $117.9M (up 137% YoY), net income $9.4M vs loss; reaffirms FY22 guidance $400-420M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q1 revenue $117.9M (up 137% YoY); net income $9.4M vs net loss $2.0M in Q1 2021.","Adjusted EBITDA $13.6M vs $0.4M a year ago; Mobile Health revenue $90.1M, Medical Transport $27.8M.","Covid testing revenue ~$38M (32% of total), down from 41% in Q4 2021 as transition to non-Covid services.","FY2022 revenue guidance reaffirmed at $400-420M (25-32% growth); Adjusted EBITDA guidance $35-41M.","Hired Lee Bienstock as COO from Google; new contract with Aetna; launched EV ambulance initiative."],"consensus_eps_estimate":null,"consensus_eps_actual":0.09,"consensus_revenue_estimate":null,"consensus_revenue_actual":117891552.0,"consensus_period":"2022-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":63563910.896159306,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2022-05-10T23:59:59+00:00|376493"}